Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

More to the point, perhaps, the patient had received chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell therapy is ...

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

Ribonucleic acid (RNA) molecules may be best known for their job ferrying the genetic information encoded in DNA to a cell's ...

The product discussed herein, Stem Cell Restore by Green Valley Natural Solutions, is not intended to diagnose, treat, cure, ...

During a live event, Krish Patel, MD, discussed barriers to using bispecific T-cell engagers and practical considerations of ...

New science shows age reversal may be within reach by targeting cellular aging mechanisms and restoring youthful biological ...

New research reveals that cells don't always become round before dividing, challenging over a century of textbook biology.